Cellix Biosciences, Inc. — Form D/A
Cellix Biosciences, Inc. of NEWARK, NJ, a company, filed a Form D amendment with the SEC on 2021-03-18. The offering totals $3.0M, of which $1.5M was reported sold. Industry: Other.
Offering
- Filed: 2021-03-18
- Form: D/A
- Accession: 0001772419-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.5M
- Remaining: $1.5M
- Investors: 8
- Date of first sale: 2019-03-20
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-336224
Issuer
- Name: Cellix Biosciences, Inc.
- CIK: 0001772419
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: NJIT-EDC BUILDING #524 211 WARREN STREET, NEWARK, NJ, 07103
- Phone: 862-485-7489
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Subramaniam Apparsundaram | Director | Newark, NJ |
| Mahesh Kandula | Director | Newark, NJ |
| Jaideep Khanna | Director | Newark, NJ |
| Subramaniam Apparsundaram | Executive Officer | Newark, NJ |
| Subramaniam Apparsundaram | Promoter | Newark, NJ |
| Jaideep Khanna | Related Person | Newark, NJ |
| Mahesh Kandula | Related Person | Newark, NJ |
| Subramaniam Apparsundaram | Related Person | Newark, NJ |
Other filings by this issuer (1)
More